Top Markets
Coin of the day
Health-Chem Corporation Health-Chem Corporation

Health-Chem Corporation

HCLC
Rang in Aktien #40843
Health-Chem Corporation, operating through its subsidiary, Transderm... Health-Chem Corporation, operating through its subsidiary, Transderm Laboratories Corporation, specializes in the research, development, manufacturing, and commercialization of transdermal drug delivery systems throughout the United States. Among its key products are transdermal nitroglycerin patches, formulated to provide relief for vascular and cardiovascular symptoms linked to angina pectoris (commonly known as chest pain) via skin absorption. The company additionally offers contract research and development services to third-party clients. Health-Chem Corporation employs a multifaceted sales strategy, directly engaging with wholesalers, distributors, prominent retail pharmacy chains, mail-order pharmacies, and group purchasing organizations. Its products also reach the market indirectly through independent pharmacies, managed care organizations, hospitals, nursing homes, and pharmacy benefit management firms. Founded in 1970, the company's headquarters are situated in Emigsville, Pennsylvania.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2025-01-02
Marktkapitalisierung
$73.99K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Health-Chem Corporation (HCLC)

Kategorie

Aktien-Split-Historie für Health-Chem Corporation (HCLC)
Die Aktie Health-Chem Corporation (Symbol: HCLC) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 13, 2026 statt.
Eine HCLC-Aktie, die vor dem Aug 13, 2026 gekauft wurde, entspricht heute 0 HCLC-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
8 x34
US
7 x47
US
0 -
CN
0 -
US
4 x15
US